Nosology of psychoses in DSM-5: Inches ahead but miles to go

Schizophrenia Research

Volumn 150, Issue 1, 2013, Pages 40-41

  Keshavan, Matcheri S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

DSM 5; Nosology; Schizophrenia

Indexed keywords

CLINICAL EFFECTIVENESS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DSM-5; DSM-III-R; DSM-IV; ENDOPHENOTYPE; HUMAN; ICD-10; INTERMETHOD COMPARISON; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL HEALTH CARE; NOTE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

DSM-5; NOSOLOGY; SCHIZOPHRENIA;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS;

EID: 84884133744     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.07.032     Document Type: Note

References (19)

1. Psychiatric Association American Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Press, (fifth revision).
2. Barch D.M., Bustillo J., Gaebel W., Gur R., Heckers S., Malaspina D., Owen M.J., Schultz S., Tandon R., Tsuang M., van Os J., Carpenter W. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr. Res. 2013.
3. Cuthbert B.N., Insel T.R. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr. Bull. 2010, 36(6):1061-1062.
4. Gaebel W., Zielasek J., Cleveland H. Psychotic disorders in ICD-11. Asian J. Psychiatry 2013, 6(3). 10.1016/j.ajp.2013.04.002.
5. Heckers S., Barch D.M., Bustillo J., Gaebel W., Gur R., Malaspina D., Owen M.J., Schultz S., Tandon R., Tsuang M., Van Os J., Carpenter W. Structure of the psychotic disorders classification in DSM-5. Schizophr. Res. 2013, 150(1):1-14.
6. Hill S.K., Reilly J.L., Keefe R.S., Gold J.M., Bishop J.R., Gershon E.S., Tamminga C.A., Pearlson G.D., Keshavan M.S., Sweeney J.A. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar and Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am. J. Psychiatry 2013, (Epub ahead of print).
7. Insel T.R. Rethinking schizophrenia. Nature 2010, 468(November (7321)):187-193.
8. Ivleva E.I., Morris D.W., Moates A.F., Suppes T., Thaker G.K., Tamminga C.A. Genetics and intermediate phenotypes of the schizophrenia-bipolar disorder boundary. Neurosci. Biobehav. Rev. 2010, 34(6):897-921.
9. Ivleva E.I., Bidesi A.S., Thomas B.P., Meda S.A., Francis A., Moates A.F., Witte B., Keshavan M.S., Tamminga C.A. Brain gray matter phenotypes across the psychosis dimension. Psychiatry Res. 2012, 204(1):13-24.
10. Kapur S., Phillips A.G., Insel T.R. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?. Mol. Psychiatry 2012, 17(12):1174-1179.
11. Keefe R.S. Should cognitive impairment be included in the diagnostic criteria for schizophrenia?. World Psychiatry 2008, 7(1):22-28.
12. Keshavan M.S., Morris D.W., Sweeney J.A., Pearlson G., Thaker G., Seidman L.J., Eack S.M., Tamminga C. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr. Res. 2011, 133(1-3):250-254.
13. Keshavan M.S., Clementz B.A., Pearlson G.D., Sweeney J.A., Tamminga C.A. Reimagining psychoses: an agnostic approach to diagnosis. Schizophr. Res. 2013, 146(1-3):10-16.
14. Malaspina D., Owen M.J., Heckers S., Tandon R., Bustillo J., Schultz S., Barch D.M., Gaebel W., Gur R.E., Tsuang M., Van Os J., Carpenter W. Schizoaffective Disorder in the DSM-5. Schizophr. Res. 2013, 150(1):21-25.
15. Malhi G.S., Green M., Fagiolini A., et al. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord. 2008, 10:215-230.
16. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
17. Smoller J.W., Craddock N., Kendler K., Lee P.H., Neale B.M., Nurnberger J.I., Ripke S., Santangelo S., Sullivan P.F. Cross-disorder group of the psychiatric genomics consortium, identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381(9875):1371-1379. (20).
18. Tandon R., Gaebel W., Barch D.M., Bustillo J., Gur R.E., Heckers S., Malaspina D., Owen M.J., Schultz S., Tsuang M., van Os J., Carpenter W. Definition and description of schizophrenia in the DSM-5. Schizophr. Res. 2013, 150(1):3-10.
19. Tandon R., Heckers S, Bustillo J., Barch D.M., Gaebel W., Gur R.E., Malaspina M., Owen M.J., Schulz S., Tsuang M.T., Van Os J., Carpenter W. Catatonia in DSM-5. Schizophr. Res. 2013, 150(1):26-30.